Literature DB >> 15581021

The neuropathology of melioidosis: two cases and a review of the literature.

B Koszyca1, B J Currie, P C Blumbergs.   

Abstract

Melioidosis is an infectious disease caused by Burkholderia pseudomallei and is hyperendemic in the Top End of the Northern Territory of Australia, as well as being widespread throughout tropical south east Asia. The infection is primarily acquired via the inoculation of compromised surface tissues by contaminated soils and water and it can cause an acute, rapidly fatal illness. Although pneumonia is the commonest manifestation, neurological presentations have been described, most notably encephalomyelitis. This paper presents the neuropathology of 2 fatal cases of neurological melioidosis and reviews the relevant literature.

Entities:  

Mesh:

Year:  2004        PMID: 15581021

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  10 in total

Review 1.  Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Authors:  Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Neurologic melioidosis.

Authors:  Martin Deuble; Chloe Aquilina; Robert Norton
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

3.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

4.  Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation.

Authors:  James A St John; Heidi Walkden; Lynn Nazareth; Kenneth W Beagley; Glen C Ulett; Michael R Batzloff; Ifor R Beacham; Jenny A K Ekberg
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

5.  In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model.

Authors:  Shane Massey; Katie Johnston; Tiffany M Mott; Barbara M Judy; Brian H Kvitko; Herbert P Schweizer; D Mark Estes; Alfredo G Torres
Journal:  Front Microbiol       Date:  2011-08-26       Impact factor: 5.640

6.  Neurotropic threat characterization of Burkholderia pseudomallei strains.

Authors:  Jodie Morris; Anne Fane; Catherine Rush; Brenda Govan; Mark Mayo; Bart J Currie; Natkunam Ketheesan
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

7.  Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia.

Authors:  Jodie L Morris; Anne Fane; Derek S Sarovich; Erin P Price; Catherine M Rush; Brenda L Govan; Elizabeth Parker; Mark Mayo; Bart J Currie; Natkunam Ketheesan
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

8.  A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis.

Authors:  David A Revelli; Julie A Boylan; Frank C Gherardini
Journal:  Front Cell Infect Microbiol       Date:  2012-12-20       Impact factor: 5.293

9.  Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis.

Authors:  Richard J Thomas; C Davies; A Nunez; S Hibbs; L Eastaugh; S Harding; J Jordan; K Barnes; P Oyston; S Eley
Journal:  Front Cell Infect Microbiol       Date:  2012-07-23       Impact factor: 5.293

10.  Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis.

Authors:  James A St John; Jenny A K Ekberg; Samantha J Dando; Adrian C B Meedeniya; Rachel E Horton; Michael Batzloff; Suzzanne J Owen; Stephanie Holt; Ian R Peak; Glen C Ulett; Alan Mackay-Sim; Ifor R Beacham
Journal:  mBio       Date:  2014-04-15       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.